Rapid Communication| Volume 22, ISSUE 2, P195-198, March 2023

A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques

Published:November 21, 2022DOI:



      The current standard of care for muscle-invasive bladder cancer is neoadjuvant chemotherapy followed by radical cystectomy with lymph node dissection. Although this treatment provides therapeutic benefit, it is associated with notable morbidity. Bladder sparing techniques, such as concurrent chemo-radiation, are less invasive and prioritize organ preservation in individuals with invasive bladder cancer and offer comparable disease control. High-dose-rate brachytherapy is an emerging paradigm in the management of muscle-invasive bladder cancer. During high-dose-rate brachytherapy, radioactive sources are introduced to the area of the primary tumor through specialized catheters. The specific placement of brachytherapy catheters results in heightened effectiveness of the radiation treatment with less radiation damage to surrounding structures. For bladder-sparing therapies such as brachytherapy to rival radical cystectomy, these techniques need to be refined further by radiation oncologists.


      One such modality for developing and practicing these techniques is the use of cadaveric models in innovation-focused clinical training facilities, which provide a simulated sterile surgical environment without the concern for extending intraoperative time.

      Findings and conclusions

      The objective of this technical note is to demonstrate how clinical training facilities such as the Houston Methodist Institute for Technology, Innovation & Education are ideal for the development, testing, and training of novel brachytherapy techniques using cadaveric models. By utilizing a network of similarly innovative training centers, research and development of brachytherapy techniques can be expedited, and novel bladder-sparing treatment methods can be implemented as the standard of care for bladder cancer.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Pieters B.R.
        • van der Steen-Banasik E.
        • Smits G.A.
        • et al.
        GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma.
        Radiother Oncol. 2017; 122: 340-346
        • Pos F.
        • Horenblas S.
        • Dom P.
        • et al.
        Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?.
        Int J Radiat Oncol Biol Phys. 2005; 61: 678-686
        • Kulkarni G.S.
        • Hermanns T.
        • Wei Y.
        • et al.
        Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic.
        J Clin Oncol. 2017; 35: 2299-2305
        • Marwaha G.
        • Macklis R.
        • Singh A.D.
        • et al.
        Dev Ophthalmol. 2013; 52: 29-35
        • Gilbody J.
        • Prasthofer A.W.
        • Ho K.
        • et al.
        The use and effectiveness of cadaveric workshops in higher surgical training: a systematic review.
        Ann R Coll Surg Engl. 2011; 93: 347-352
        • Held J.M.
        • McLendon R.B.
        • McEvoy C.S.
        • et al.
        A reusable perfused human cadaver model for surgical training: an initial proof of concept study.
        Mil Med. 2019; 184: 43-47